Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Digital Tech Advancing Disease Management

Getting your Trinity Audio player ready...

University of Michigan researchers have uncovered a connection between cellular mechanisms associated with cystic fibrosis and a rare disease called cystinosis, using insights from the world of digital technology. These mechanisms involve the cleanup of mutated proteins and their impact on cell health.

In cystinosis, a genetic disorder, malfunctioning cellular mechanisms lead to the accumulation of cystine crystals within cells, causing cell disruption and harm to tissues and organs, particularly the kidneys and eyes. The root of this problem lies in the lysosome, known as the cell’s recycling centre, which usually processes cellular waste, breaks it down into reusable materials, and reintroduces them into the cell.

However, when a protein responsible for transporting recycled amino acids back into the cell mutates and fails, a cellular process called endoplasmic-reticulum-associated degradation (ERAD) comes into play. ERAD cleans up the faulty protein, allowing amino acids like cystine to accumulate within the lysosome.

To tackle this issue, Varsha Venkatarangan, a graduate student at the University of Michigan, conducted experiments using fibroblasts derived from patients with cystinosis. She discovered that ERAD was the mechanism at play, causing the rapid degradation of mutant proteins. Notably, ERAD is also involved in other diseases, including a significant form of cystic fibrosis.

The significance of digital technology is increasingly indispensable in modern healthcare. This revelation serves as a compelling testament to the pivotal role that digital technology plays in managing diseases and has the potential to revolutionise the healthcare field. Notably, the application of chemical chaperones, a prime example of precision medicine, brings to light the convergence of cutting-edge biological research and innovative digital solutions.

The implications of this discovery extend beyond cystinosis, reaching into the realm of personalised medicine. With the ability to target specific genetic mutations using digital tools, medical researchers are advancing towards treatments that cater to the unique genetic makeup of individual patients. This shift from a one-size-fits-all approach to tailored interventions marks a significant advancement in healthcare. It exemplifies how tailored interventions, guided by genetic insights and facilitated by digital technology, are becoming increasingly feasible and promising.

“This intersection of biology and digital technology is opening up new frontiers in healthcare, offering fresh insights and opportunities for more effective treatments,” Varsha said.

Moreover, integrating digital technology in healthcare is more comprehensive than precision medicine. It encompasses many applications, from artificial intelligence-powered diagnostics to remote patient monitoring using wearable devices. These digital innovations promise to enhance patient care, streamline processes, and improve overall health outcomes.

As researchers continue to explore the intersection of biology and digital technology, people can anticipate a wave of transformative breakthroughs that have the potential to reshape the landscape of healthcare. From early disease detection to more precise and effective treatments, the fusion of these disciplines heralds a new era in healthcare, where individualised care based on genetic profiles becomes the norm, ultimately leading to improved patient outcomes and a higher quality of life.

Varsha emphasised, “This synergy between biology and digital innovation has the potential to usher in a new era of personalised medicine, where treatments are tailored to individual genetic profiles, promising a brighter future for healthcare.”


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.